Myocarditis Cases After Vaccination Higher than Cases After COVID-19 Infection

A dramatic increase in myocarditis cases starting in 2021 has been seen. Studies and insurance companies’ records show that myocarditis reports found in the VAERS system, which is used by the CDC in its analysis, underestimate the number of myocarditis cases by somewhere between 300–400 percent.

CDC Data Suggests Myocarditis Cases Could Be 2 Times Higher After Vaccination Than After Contracting COVID-19 | Facts Matter

Myocarditis is inflammation of the heart muscle that can be most commonly caused by a viral infection, and by various types of agents, such as drugs, medications, autoimmune diseases, and also vaccines. Inflammation in the heart can lead to actual muscle breakdown, cardiomaiopathy, which is the deterioration of function, and arrhythmias. All these can have fatal complications if they worsen, explains Dr. Sanjay Verma, an interventional cardiologist in Southern California, the guest of this Facts Matter episode.

According to his expertise, there’s a very strong age factor in myocarditis, and it tends to peak in adolescents around 15-17 years old. Within the general population, myocarditis can occur in about eight per million for all age groups and about eighteen per million adolescents. It tends to have a bigger occurrence in males, where about 66% of all cases are men.

Myocarditis as a side effect of COVID-19

Myocarditis depends on the agent causing it. Coxsackie virus and even influenza virus infection would cause direct viral damage. An immune reaction would be another instance, and Dr. Verma gives the example of the antibodies to the spike protein developed by a person’s body that is attacking the heart.

When it comes to COVID-19 causing myocarditis, Dr. Verma explains how the Sars-Cov2’s spike protein has a direct toxic effect on the sarcomeres, which are the cells of the heart muscle. This can be mediated by an immune reaction, and also cytotoxic intracellular damage, specifically mitochondrial dysfunction. Since mid-2020, according to research, the spike protein had been known to cause “endothelial dysfunction.” This means that in addition to the damage to the heart muscle, it also causes endothelial dysfunction, which causes damage to the blood vessels, which can be related to stroke, blood clots, and also damage to the coronary arteries causing heart attacks or severe spasm.

In mid-2020, around the time when vaccine development was in process, some published papers talked about “antigen mimicry.” This phenomenon refers to the spike protein having a morphology similar to antigens or parts of our own body where autoimmune reactions can be a concern. Early reports of vaccine associated myocarditis from Israel surfaced in April 2021, suggesting this reaction is common in one out of 3000 people.

Myocarditis after COVID-19 vaccination vs. Sars-CoV2 infection

According to the CDC, the rate of myocarditis from natural infection is significantly greater than that from the vaccine, based on their analysis of data from the self-reporting system VAERS. A few studies coming from Ontario Canada, Hong Kong, Martina Patone’s study from the UK, and others from Israel look at incidence rates, especially for younger adults. They come with a preponderance of evidence suggesting that incidents of myocarditis after vaccination, especially in males older than 40, are in fact higher than after infection.

Dr. Verma continues by mentioning that the cases are probably twice as many after vaccination vs. the ones after infection. In heterologous dosing, meaning getting the first dose of vaccine from Pfizer for example, and the second dose from Moderna, the rates go to three to four times greater than after infection. This is partially due to the dosing and interval of spike protein being different for each vaccine manufacturer. So, the amount of mRNA that is produced between each of them might be different, with some studies showing how the mRNA spike protein can be found in the blood circulation beyond the injection site for four weeks or even four months after injection.

The CDC’s data is collected only for 7 days, and mostly up to 21 days after vaccination, while M. Patone’s study previously mentioned collected data up to 28 days after hospital discharge, finding even increased mortality. The study that came from Israel even went further up to 6 months and found that COVID infection did not have a statistically increased risk of causing myocarditis.

Sudden Adult Death Syndrome

Myocarditis presents an increased risk of sudden cardiac death for up to 6 months after diagnosis. Guidelines on myocarditis recommend three to six months of activity restriction from competitive sports. The exact mechanism of how sudden cardiac death occurs is not entirely known. One of the hypotheses is that myocarditis leads to scar formation, which can result in an increased risk of fatal ventricular arrhythmias.

Sudden Adult Death Syndrome, or SADS, refers to the cases of patients who did not have a severe infection, or an accident, or a certain heart condition, and there was no use of drugs or other substances. So, without any precipitating cause, the patient has a sudden death that is not able to be explained otherwise.

According to available data, from 1960 to the year 2004 there were around 23 sudden deaths per year in the athletes’ community, going up to 65-75 per year between 2005 and 2006. The collected number went up to 500 for the year of 2022 alone, according to Dr. Verma. The data from insurance companies also shows a spike in deaths in September 2021.

Physicians who want to talk about this on social media experience a lot of censorship. Even more, the California legislature recently introduced an Assembly bill that will consider it to be unprofessional conduct if a physician says anything contrary to CDC recommendations on COVID-19 vaccination data will risk losing their medical license. Dr. Verma considers this as a huge discouragement for open discussions on risks and benefits, which is contrary to all notions of medical ethics that require informed consent and quantified discussion of risks and benefits.

Dr. Verma’s research and experience brought forth a lot of information, especially regarding the sources of data that can be obtained, explaining each process of collecting the specific data, and preparing the statistics. It also makes it very easy to understand what myocarditis is, and how it can be diagnosed.

---

Watch the trailer:

Click to watch the full video with an EpochTV subscription. ($1 for 2 months trial available ) CDC Data Suggests Myocarditis Cases Could Be 2 Times Higher After Vaccination Than After Contracting COVID-19 | Facts Matter

Dr. Sanjay Verma is an interventional cardiologist in Southern California. In this interview, he discusses several medical studies on myocarditis and sudden adult death syndrome (SADS) events that contradict the mainstream narrative on vaccine side effects, while interjecting his own experiences in which he’s seen a dramatic increase in myocarditis cases starting in 2021.

Dr. Verma references a couple of studies that compared myocarditis reports in the VAERS system with insurance database records of myocarditis reports. The studies found that the VAERS system underestimates the number of myocarditis cases by somewhere between 300–400 percent.